Dose intensified preoperative chemotherapy with doxorubicin/docetaxel in operable breast cancer - A phase II trial

被引：0
|
作者：
Blohmer, JU
Tulusan, AH
Jackisch, C
Kaufmann, M
Costa, SD
von Minckwitz, G
Eiermann, W
机构：
[1] Univ Frankfurt, Womens Hosp, D-6000 Frankfurt, Germany
[2] Univ Munster, Womens Hosp, D-4400 Munster, Germany
[3] Univ Bayreuth, Womens Hosp, Bayreuth, Germany
[4] Univ Bern, Womens Hosp, Berlin, Germany
[5] Rot Kreuz Krh, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
33P
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer
    Ganem, G
    Tubiana-Hulin, M
    Fumoleau, P
    Combe, M
    Misset, JL
    Vannetzel, JM
    Bachelot, T
    De Ybarlucea, LR
    Lotz, V
    Bendahmane, B
    Dieras, V
    ANNALS OF ONCOLOGY, 2003, 14 (11) : 1623 - 1628
  • [2] PHASE II STUDY OF DOCETAXEL AND DOXORUBICIN COMBINATION AS NEOADJUVANT CHEMOTHERAPY IN OPERABLE BREAST CANCER PATIENTS
    Uddin, D.
    Hannan, A. A.
    Ahmed, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 92 - 92
  • [3] Phase II Trial of Dose Dense Docetaxel Followed by FEC100 as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer
    Jacot, William
    Bibeau, Frederic
    Gourgou-Bourgade, Sophie
    Gutowski, Marian
    Colombo, Pierre-Emmanuel
    Bleuse, Jean-Pierre
    Kramar, Andrew
    Romieu, Gilles
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 544 - 549
  • [4] Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer
    Cooper, Brenda W.
    Radivoyevitch, Tomas
    Overmoyer, Beth A.
    Shenk, Robert R.
    Pham, Huong T.
    Samuels, Judith R.
    Parry, Margaret P.
    Silverman, Paula
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (03) : 311 - 318
  • [5] Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer
    Brenda W. Cooper
    Tomas Radivoyevitch
    Beth A. Overmoyer
    Robert R. Shenk
    Huong T. Pham
    Judith R. Samuels
    Margaret P. Parry
    Paula Silverman
    Breast Cancer Research and Treatment, 2006, 97 : 311 - 318
  • [6] Phase II trial of the combination docetaxel and doxorubicin as neoadjuvant chemotherapy in locally advanced or inflammatory inoperable breast cancer
    Chahine, Georges Y.
    Dagher, Joya E.
    Sleilaty, Ghassan S.
    El Karak, Fadi R.
    ANNALS OF ONCOLOGY, 2004, 15 : 32 - 32
  • [7] Primary chemotherapy with gemcitabine, doxorubicin and docetaxel for early breast cancer: Final results of a Phase-II trial
    Mross, Klaus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (07) : 423 - 424
  • [8] Phase II study of sequential docetaxel (Taxotere®, TXT) and doxorubicin (Dox) as primary chemotherapy (CT) for large operable breast cancer (BC)
    Laurence, V
    Girre, V
    Extra, JM
    Dieras, V
    Palangie, T
    Dorval, J
    Pierga, JY
    Jouve, M
    Beuzeboc, P
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S203 - S203
  • [9] Treatment of metastatic breast cancer with intensified combination of docetaxel and mitoxantrone: A multicenter phase II trial
    Alexopoulos, A
    Malamos, N
    Giannakakis, T
    Mauroudis, D
    Panagos, G
    Agelaki, S
    Kosmas, C
    Souglakos, J
    Vardakis, N
    Apostolaki, F
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 27 - 27
  • [10] Phase II trial report of the new preoperative chemotherapy with S-1 and docetaxel for advanced breast cancer.
    Nakagawa, M.
    Aoyama, M.
    Ikeda, M.
    Morimoto, M.
    Takechi, H.
    Kawakami, Y.
    Kennzaki, K.
    Tangoku, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345